Leukemia, Lymphoid
Showing 5326 - 5350 of 5,405
B-CLL Trial in Stockholm (alemtuzumab)
Completed
- B-CLL
-
Stockholm, SwedenDept. of Hematology, Karolinska University Hospital
Jul 23, 2007
AML Trial in Frankfurt (Glivec, Mitoxantrone, Topotecan)
Unknown status
- AML
- Glivec
- +3 more
-
Frankfurt, GermanyUniversity of Frankfurt, Medical Dept. II
Aug 28, 2008
Immunological and Stem Cell Function in Peripheral Blood
Completed
- Immunologic Deficiency Syndrome
- +3 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Acute Myeloid Leukemia, Elderly Trial in Kansas City (Azacitidine)
Unknown status
- Acute Myeloid Leukemia
- Elderly
-
Kansas City, MissouriKansas City Veterans Affairs Medical Center
Aug 5, 2008
Leukemia, Lymphocytic, Acute Trial in Angers (interferon alpha 2a)
Completed
- Leukemia, Lymphocytic, Acute
- interferon alpha 2a
-
Angers, chu ANGERS, FranceINorbert IFRAH
Jun 5, 2007
Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in New York (AQ4N (Chemotherapy))
Unknown status
- Non-Hodgkin's Lymphoma
- +2 more
- AQ4N (Chemotherapy)
-
New York, New YorkWeill Medical College of Cornell University/ New York Presbyteri
May 4, 2007
Acute Promyelocytic Leukemia Trial in Santa Monica, (NRX 195183 Soft Gelatin Capsule)
Unknown status
- Acute Promyelocytic Leukemia
- NRX 195183 Soft Gelatin Capsule
-
Santa Monica,, CaliforniaSarcoma Oncology Center
May 9, 2008
Osteoporosis in Children With ALL
Completed
- Leukemia, Lymphocytic, Acute, L1
-
Kansas City, MissouriChildren's Mercy Hospital
Apr 5, 2007
Adult Acute Lymphocytic Leukemia T-Cell, Lymphoma, Lymphoblastic Trial in Frankfurt (Alemtuzumab (MabCampath), Cladribine)
Completed
- Adult Acute Lymphocytic Leukemia T-Cell
- Lymphoma, Lymphoblastic
- Alemtuzumab (MabCampath)
- Cladribine
-
Frankfurt, GermanyUniversity Hospital, Medical Dept. II
May 29, 2008
Acute Myeloid Leukemia Trial in Memphis (Busulfan, Cyclophosphamide, Mesna)
Completed
- Acute Myeloid Leukemia
- Busulfan
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 25, 2008
Breast Tumors, Lymphoma, Tumor Metastasis Trial run by the NCI (interleukin-1)
Completed
- Breast Neoplasms
- +3 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Leukemia, T-Cell, Lymphoma, T-Cell, Cutaneous Trial run by the NCI (Yttrium-90 radiolabeled anti-Tac antibody)
Completed
- Leukemia, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Yttrium-90 radiolabeled anti-Tac antibody
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Pediatric Acute Leukemia Induction Trial in New Delhi (ORAL VORICONAZOLE and IV Amphotericin B)
Unknown status
- Pediatric Acute Leukemia Induction
- ORAL VORICONAZOLE and IV Amphotericin B
-
New Delhi, Delhi, IndiaInstitute Rotary Cancer Hospital, All India Institute of Medical
Feb 19, 2008
Hairy Cell Leukemia Trial run by the NCI (Roferon-A)
Completed
- Hairy Cell Leukemia
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Acute Lymphocytic Leukemia, Leukemia Trial run by the NCI (Vincristine)
Completed
- Acute Lymphocytic Leukemia
- Leukemia
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Acute Myelogenous Leukemia Trial in United States (GVAX leukemia vaccine (therapeutic cellular vaccine, GM-CSF producing))
Completed
- Acute Myelogenous Leukemia
- GVAX leukemia vaccine (therapeutic cellular vaccine, GM-CSF producing)
-
San Francisco, California
- +3 more
Dec 18, 2007
HIV, Immunologic Deficiency Syndromes, Lymphoproliferative Disorders Trial run by the NCI (all-trans-retinoic acid with
Completed
- HIV Infections
- +2 more
- all-trans-retinoic acid with IFN-alpha2a
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
HTLV-I Infection, Spinal Cord Disease, Tropical Spastic Paraparesis Trial run by the NINDS (Recombinant human interferon
Completed
- HTLV-I Infection
- +2 more
- Recombinant human interferon beta-1a
-
Bethesda, MarylandNational Institute of Neurological Disorders and Stroke (NINDS)
Mar 3, 2008
Leukemia, Lymphoma Trial run by the (BL22 immunotoxin, antibody-drug conjugate therapy, immunotoxin therapy)
Suspended
- Leukemia
- Lymphoma
- BL22 immunotoxin
- +3 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Dec 21, 2007
Acute Myeloid Leukemia Trial in France (Two post-remission strategies, Idarubicin versus daunorubicin)
Terminated
- Acute Myeloid Leukemia
- Two post-remission strategies
- Idarubicin versus daunorubicin
-
Bobigny, France
- +12 more
Feb 20, 2008